Offering support to those impacted in Turkey & Syria
Offering support to those impacted in Turkey & Syria
We are deeply saddened by the tragic earthquake across Turkey and Syria and the worsening humanitarian crisis. Our thoughts are with all of those impacted by the devastating events and our gratitude to those who are bravely leading the rescue efforts.
As part of our commitment to ensuring patients have access to treatments, Ipsen will be donating financial and medical aid to the value of €100K to help those in need. We are collaborating with Association Tulipe, a humanitarian distribution establishment which federates donations from health companies to populations in distress. We are also working closely with a local distributor to deliver donations of critical medicines to care providers delivering aid across the regions.
We will continue to closely follow the situation and stand in solidarity with those affected.
Offering support to those impacted in Turkey & Syria
We are deeply saddened by the tragic earthquake across Turkey and Syria and the worsening humanitarian crisis. Our thoughts are with all of those impacted by the devastating events and our gratitude to those who are bravely leading the rescue efforts.
As part of our commitment to ensuring patients have access to treatments, Ipsen will be donating financial and medical aid to the value of €100K to help those in need. We are collaborating with Association Tulipe, a humanitarian distribution establishment which federates donations from health companies to populations in distress. We are also working closely with a local distributor to deliver donations of critical medicines to care providers delivering aid across the regions.
We will continue to closely follow the situation and stand in solidarity with those affected.
Related Updates
Ipsen provides clarifications regarding the succession of Mr. Henri Beaufour...
Ipsen expands pre-clinical pipeline in rare neurodegenerative diseases
Ipsen Statement on Lanreotide Generic Supply Challenges
Ipsen, Université de Montréal and IRICoR expand long-term partnership to...
Ipsen provides update on legacy of Henri Beaufour
Ipsen announces the conclusion of an agreement between its main...
ESMO 2025: new data reinforces breadth and depth of Ipsen’s...
Ipsen to present data across five rare liver diseases at...
Ipsen to present new data across four rare liver diseases...
Ipsen announces assigned Investment Grade ratings from S&P Global Ratings...